Trial Profile
A phase 1/2 study of ADX-103
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 04 Jul 2018
Price :
$35
*
At a glance
- Drugs ADX 103 (Primary)
- Indications Eye disorders
- Focus Adverse reactions; Therapeutic Use
- 04 Jul 2018 New trial record
- 26 Jun 2018 According to an Aldeyra Therapeutics media release, this study is expected to start in 2019.